These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19039952)
21. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants. Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462 [TBL] [Abstract][Full Text] [Related]
22. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs. Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C). Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411 [TBL] [Abstract][Full Text] [Related]
24. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477 [TBL] [Abstract][Full Text] [Related]
25. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486 [TBL] [Abstract][Full Text] [Related]
26. Immunoprotective mechanisms in swine within the "grey zone" in antibody response after immunization with foot-and-mouth disease vaccine. Zhang L; Feng X; Jin Y; Ma J; Cai H; Zhang X Virus Res; 2016 Jul; 220():39-46. PubMed ID: 27067203 [TBL] [Abstract][Full Text] [Related]
27. Recombinant pseudorabies virus expressing P12A and 3C of FMDV can partially protect piglets against FMDV challenge. Zhang K; Huang J; Wang Q; He Y; Xu Z; Xiang M; Wu B; Chen H Res Vet Sci; 2011 Aug; 91(1):90-94. PubMed ID: 20947111 [TBL] [Abstract][Full Text] [Related]
28. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge. Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957 [TBL] [Abstract][Full Text] [Related]
29. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge. Wang G; Pan L; Zhang Y; Wang Y; Zhang Z; Lü J; Zhou P; Fang Y; Jiang S PLoS One; 2011; 6(11):e27605. PubMed ID: 22110686 [TBL] [Abstract][Full Text] [Related]
30. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine. Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990 [TBL] [Abstract][Full Text] [Related]
31. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease. You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913 [TBL] [Abstract][Full Text] [Related]
32. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Moraes MP; Mayr GA; Mason PW; Grubman MJ Vaccine; 2002 Feb; 20(11-12):1631-9. PubMed ID: 11858872 [TBL] [Abstract][Full Text] [Related]
33. A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease. Fowler V; Robinson L; Bankowski B; Cox S; Parida S; Lawlor C; Gibson D; O'Brien F; Ellefsen B; Hannaman D; Takamatsu HH; Barnett PV Antiviral Res; 2012 Apr; 94(1):25-34. PubMed ID: 22330893 [TBL] [Abstract][Full Text] [Related]
34. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease. Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894 [TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV). Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860 [TBL] [Abstract][Full Text] [Related]
36. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Moraes MP; Chinsangaram J; Brum MC; Grubman MJ Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155 [TBL] [Abstract][Full Text] [Related]
38. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle. Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542 [TBL] [Abstract][Full Text] [Related]
39. A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs. Shao J; Liu W; Gao S; Chang H; Guo H Virology; 2024 Aug; 596():110103. PubMed ID: 38781710 [TBL] [Abstract][Full Text] [Related]
40. CpG-enriched plasmid enhances the efficacy of the traditional foot-and-mouth disease killed vaccine. Guo X; Jia H; Zhang Q; Yuan W; Zhu G; Xin T; Zhu H; Sánchez-Vizcaíno JM Microbiol Immunol; 2012 May; 56(5):332-7. PubMed ID: 22335800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]